ID   LKHA4_RAT               Reviewed;         611 AA.
AC   P30349; Q499P2;
DT   01-APR-1993, integrated into UniProtKB/Swiss-Prot.
DT   02-DEC-2020, sequence version 3.
DT   02-OCT-2024, entry version 166.
DE   RecName: Full=Leukotriene A-4 hydrolase;
DE            Short=LTA-4 hydrolase;
DE            EC=3.3.2.6 {ECO:0000269|PubMed:1544505};
DE   AltName: Full=Leukotriene A(4) hydrolase;
DE   AltName: Full=Tripeptide aminopeptidase LTA4H {ECO:0000305};
DE            EC=3.4.11.4 {ECO:0000250|UniProtKB:P09960};
GN   Name=Lta4h;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], CATALYTIC ACTIVITY, FUNCTION, AND ACTIVITY
RP   REGULATION.
RX   PubMed=1544505; DOI=10.1016/0014-5793(92)80130-9;
RA   Makita N., Funk C.D., Imai E., Hoover R.L., Badr K.F.;
RT   "Molecular cloning and functional expression of rat leukotriene A4
RT   hydrolase using the polymerase chain reaction.";
RL   FEBS Lett. 299:273-277(1992).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Prostate;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Brown Norway;
RX   PubMed=15057822; DOI=10.1038/nature02426;
RA   Gibbs R.A., Weinstock G.M., Metzker M.L., Muzny D.M., Sodergren E.J.,
RA   Scherer S., Scott G., Steffen D., Worley K.C., Burch P.E., Okwuonu G.,
RA   Hines S., Lewis L., Deramo C., Delgado O., Dugan-Rocha S., Miner G.,
RA   Morgan M., Hawes A., Gill R., Holt R.A., Adams M.D., Amanatides P.G.,
RA   Baden-Tillson H., Barnstead M., Chin S., Evans C.A., Ferriera S.,
RA   Fosler C., Glodek A., Gu Z., Jennings D., Kraft C.L., Nguyen T.,
RA   Pfannkoch C.M., Sitter C., Sutton G.G., Venter J.C., Woodage T., Smith D.,
RA   Lee H.-M., Gustafson E., Cahill P., Kana A., Doucette-Stamm L.,
RA   Weinstock K., Fechtel K., Weiss R.B., Dunn D.M., Green E.D.,
RA   Blakesley R.W., Bouffard G.G., De Jong P.J., Osoegawa K., Zhu B., Marra M.,
RA   Schein J., Bosdet I., Fjell C., Jones S., Krzywinski M., Mathewson C.,
RA   Siddiqui A., Wye N., McPherson J., Zhao S., Fraser C.M., Shetty J.,
RA   Shatsman S., Geer K., Chen Y., Abramzon S., Nierman W.C., Havlak P.H.,
RA   Chen R., Durbin K.J., Egan A., Ren Y., Song X.-Z., Li B., Liu Y., Qin X.,
RA   Cawley S., Cooney A.J., D'Souza L.M., Martin K., Wu J.Q.,
RA   Gonzalez-Garay M.L., Jackson A.R., Kalafus K.J., McLeod M.P.,
RA   Milosavljevic A., Virk D., Volkov A., Wheeler D.A., Zhang Z., Bailey J.A.,
RA   Eichler E.E., Tuzun E., Birney E., Mongin E., Ureta-Vidal A., Woodwark C.,
RA   Zdobnov E., Bork P., Suyama M., Torrents D., Alexandersson M., Trask B.J.,
RA   Young J.M., Huang H., Wang H., Xing H., Daniels S., Gietzen D., Schmidt J.,
RA   Stevens K., Vitt U., Wingrove J., Camara F., Mar Alba M., Abril J.F.,
RA   Guigo R., Smit A., Dubchak I., Rubin E.M., Couronne O., Poliakov A.,
RA   Huebner N., Ganten D., Goesele C., Hummel O., Kreitler T., Lee Y.-A.,
RA   Monti J., Schulz H., Zimdahl H., Himmelbauer H., Lehrach H., Jacob H.J.,
RA   Bromberg S., Gullings-Handley J., Jensen-Seaman M.I., Kwitek A.E.,
RA   Lazar J., Pasko D., Tonellato P.J., Twigger S., Ponting C.P., Duarte J.M.,
RA   Rice S., Goodstadt L., Beatson S.A., Emes R.D., Winter E.E., Webber C.,
RA   Brandt P., Nyakatura G., Adetobi M., Chiaromonte F., Elnitski L.,
RA   Eswara P., Hardison R.C., Hou M., Kolbe D., Makova K., Miller W.,
RA   Nekrutenko A., Riemer C., Schwartz S., Taylor J., Yang S., Zhang Y.,
RA   Lindpaintner K., Andrews T.D., Caccamo M., Clamp M., Clarke L., Curwen V.,
RA   Durbin R.M., Eyras E., Searle S.M., Cooper G.M., Batzoglou S., Brudno M.,
RA   Sidow A., Stone E.A., Payseur B.A., Bourque G., Lopez-Otin C., Puente X.S.,
RA   Chakrabarti K., Chatterji S., Dewey C., Pachter L., Bray N., Yap V.B.,
RA   Caspi A., Tesler G., Pevzner P.A., Haussler D., Roskin K.M., Baertsch R.,
RA   Clawson H., Furey T.S., Hinrichs A.S., Karolchik D., Kent W.J.,
RA   Rosenbloom K.R., Trumbower H., Weirauch M., Cooper D.N., Stenson P.D.,
RA   Ma B., Brent M., Arumugam M., Shteynberg D., Copley R.R., Taylor M.S.,
RA   Riethman H., Mudunuri U., Peterson J., Guyer M., Felsenfeld A., Old S.,
RA   Mockrin S., Collins F.S.;
RT   "Genome sequence of the Brown Norway rat yields insights into mammalian
RT   evolution.";
RL   Nature 428:493-521(2004).
CC   -!- FUNCTION: Bifunctional zinc metalloenzyme that comprises both epoxide
CC       hydrolase (EH) and aminopeptidase activities (By similarity). Acts as
CC       an epoxide hydrolase to catalyze the conversion of LTA4 to the pro-
CC       inflammatory mediator leukotriene B4 (LTB4) (PubMed:1544505). Has also
CC       aminopeptidase activity, with high affinity for N-terminal arginines of
CC       various synthetic tripeptides. In addition to its pro-inflammatory EH
CC       activity, may also counteract inflammation by its aminopeptidase
CC       activity, which inactivates by cleavage another neutrophil attractant,
CC       the tripeptide Pro-Gly-Pro (PGP), a bioactive fragment of collagen
CC       generated by the action of matrix metalloproteinase-9 (MMP9) and
CC       prolylendopeptidase (PREPL). Involved also in the biosynthesis of
CC       resolvin E1 and 18S-resolvin E1 from eicosapentaenoic acid, two lipid
CC       mediators that show potent anti-inflammatory and pro-resolving actions
CC       (By similarity). {ECO:0000250|UniProtKB:P09960,
CC       ECO:0000269|PubMed:1544505}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H2O + leukotriene A4 = leukotriene B4; Xref=Rhea:RHEA:22324,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:57461, ChEBI:CHEBI:57463; EC=3.3.2.6;
CC         Evidence={ECO:0000269|PubMed:1544505};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:22325;
CC         Evidence={ECO:0000305|PubMed:1544505};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(5S,6S)-epoxy-(18R)-hydroxy-(7E,9E,11Z,14Z,16E)-
CC         eicosapentaenoate + H2O = resolvin E1; Xref=Rhea:RHEA:50272,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:91000, ChEBI:CHEBI:132219;
CC         Evidence={ECO:0000250|UniProtKB:P09960};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:50273;
CC         Evidence={ECO:0000250|UniProtKB:P09960};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(5S,6S)-epoxy-(18S)-hydroxy-(7E,9E,11Z,14Z,16E)-
CC         eicosapentaenoate + H2O = 18S-resolvin E1; Xref=Rhea:RHEA:51988,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:134661, ChEBI:CHEBI:136057;
CC         Evidence={ECO:0000250|UniProtKB:P09960};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:51989;
CC         Evidence={ECO:0000250|UniProtKB:P09960};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=Release of the N-terminal residue from a tripeptide.;
CC         EC=3.4.11.4; Evidence={ECO:0000250|UniProtKB:P09960};
CC   -!- COFACTOR:
CC       Name=Zn(2+); Xref=ChEBI:CHEBI:29105;
CC         Evidence={ECO:0000250|UniProtKB:P09960};
CC       Note=Binds 1 zinc ion per subunit. {ECO:0000250|UniProtKB:P09960};
CC   -!- ACTIVITY REGULATION: Inhibited by bestatin (By similarity). Inhibited
CC       by captopril (PubMed:1544505). The epoxide hydrolase activity is
CC       restrained by suicide inactivation that involves binding of LTA4 to
CC       Tyr-379. 4-(4-benzylphenyl)thiazol-2-amine (ARM1) selectively inhibits
CC       the epoxide hydrolase activity (By similarity).
CC       {ECO:0000250|UniProtKB:P09960, ECO:0000269|PubMed:1544505}.
CC   -!- PATHWAY: Lipid metabolism; leukotriene B4 biosynthesis.
CC       {ECO:0000269|PubMed:1544505}.
CC   -!- SUBUNIT: Monomer. {ECO:0000250|UniProtKB:P09960}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:P09960}.
CC   -!- PTM: Phosphorylation at Ser-416 inhibits leukotriene-A4 hydrolase
CC       activity. {ECO:0000250|UniProtKB:P09960}.
CC   -!- SIMILARITY: Belongs to the peptidase M1 family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; S87522; AAB21778.1; -; mRNA.
DR   EMBL; AABR07056638; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC099819; AAH99819.1; -; mRNA.
DR   PIR; S20444; S20444.
DR   RefSeq; NP_001025202.1; NM_001030031.1.
DR   AlphaFoldDB; P30349; -.
DR   SMR; P30349; -.
DR   IntAct; P30349; 2.
DR   STRING; 10116.ENSRNOP00000005930; -.
DR   ChEMBL; CHEMBL2400; -.
DR   MEROPS; M01.004; -.
DR   iPTMnet; P30349; -.
DR   PhosphoSitePlus; P30349; -.
DR   jPOST; P30349; -.
DR   PaxDb; 10116-ENSRNOP00000005930; -.
DR   PeptideAtlas; P30349; -.
DR   Ensembl; ENSRNOT00000005930.5; ENSRNOP00000005930.4; ENSRNOG00000004494.6.
DR   Ensembl; ENSRNOT00055009477; ENSRNOP00055007292; ENSRNOG00055005864.
DR   Ensembl; ENSRNOT00060040823; ENSRNOP00060033760; ENSRNOG00060023556.
DR   Ensembl; ENSRNOT00065019930; ENSRNOP00065015279; ENSRNOG00065012260.
DR   GeneID; 299732; -.
DR   KEGG; rno:299732; -.
DR   UCSC; RGD:1311333; rat.
DR   AGR; RGD:1311333; -.
DR   CTD; 4048; -.
DR   RGD; 1311333; Lta4h.
DR   eggNOG; KOG1047; Eukaryota.
DR   GeneTree; ENSGT00940000156375; -.
DR   HOGENOM; CLU_014505_0_0_1; -.
DR   InParanoid; P30349; -.
DR   OMA; CTALQWM; -.
DR   OrthoDB; 443480at2759; -.
DR   TreeFam; TF300758; -.
DR   BRENDA; 3.3.2.6; 5301.
DR   Reactome; R-RNO-2142691; Synthesis of Leukotrienes (LT) and Eoxins (EX).
DR   Reactome; R-RNO-6798695; Neutrophil degranulation.
DR   Reactome; R-RNO-9018676; Biosynthesis of D-series resolvins.
DR   Reactome; R-RNO-9018681; Biosynthesis of protectins.
DR   Reactome; R-RNO-9018896; Biosynthesis of E-series 18(S)-resolvins.
DR   Reactome; R-RNO-9020265; Biosynthesis of aspirin-triggered D-series resolvins.
DR   Reactome; R-RNO-9023661; Biosynthesis of E-series 18(R)-resolvins.
DR   UniPathway; UPA00878; -.
DR   PRO; PR:P30349; -.
DR   Proteomes; UP000002494; Chromosome 7.
DR   Bgee; ENSRNOG00000004494; Expressed in jejunum and 20 other cell types or tissues.
DR   GO; GO:0005829; C:cytosol; IBA:GO_Central.
DR   GO; GO:0005654; C:nucleoplasm; IEA:Ensembl.
DR   GO; GO:0005634; C:nucleus; IBA:GO_Central.
DR   GO; GO:0004177; F:aminopeptidase activity; ISS:UniProtKB.
DR   GO; GO:0004301; F:epoxide hydrolase activity; ISS:UniProtKB.
DR   GO; GO:0004463; F:leukotriene-A4 hydrolase activity; IDA:RGD.
DR   GO; GO:0070006; F:metalloaminopeptidase activity; ISO:RGD.
DR   GO; GO:0045148; F:tripeptide aminopeptidase activity; IEA:UniProtKB-EC.
DR   GO; GO:0008270; F:zinc ion binding; ISS:UniProtKB.
DR   GO; GO:0019370; P:leukotriene biosynthetic process; ISS:UniProtKB.
DR   GO; GO:0006691; P:leukotriene metabolic process; IDA:RGD.
DR   GO; GO:0043171; P:peptide catabolic process; ISS:UniProtKB.
DR   GO; GO:0006508; P:proteolysis; IEA:UniProtKB-KW.
DR   GO; GO:0043434; P:response to peptide hormone; IEP:RGD.
DR   GO; GO:0010043; P:response to zinc ion; IEP:RGD.
DR   GO; GO:0060509; P:type I pneumocyte differentiation; IEP:RGD.
DR   CDD; cd09599; M1_LTA4H; 1.
DR   Gene3D; 3.30.2010.30; -; 1.
DR   Gene3D; 1.10.390.10; Neutral Protease Domain 2; 1.
DR   Gene3D; 1.25.40.320; Peptidase M1, leukotriene A4 hydrolase/aminopeptidase C-terminal domain; 1.
DR   Gene3D; 2.60.40.1730; tricorn interacting facor f3 domain; 1.
DR   InterPro; IPR045357; Aminopeptidase_N-like_N.
DR   InterPro; IPR042097; Aminopeptidase_N-like_N_sf.
DR   InterPro; IPR016024; ARM-type_fold.
DR   InterPro; IPR012777; LTA4H.
DR   InterPro; IPR049980; LTA4H_cat.
DR   InterPro; IPR038502; M1_LTA-4_hydro/amino_C_sf.
DR   InterPro; IPR034015; M1_LTA4H.
DR   InterPro; IPR001930; Peptidase_M1.
DR   InterPro; IPR015211; Peptidase_M1_C.
DR   InterPro; IPR014782; Peptidase_M1_dom.
DR   InterPro; IPR027268; Peptidase_M4/M1_CTD_sf.
DR   NCBIfam; TIGR02411; leuko_A4_hydro; 1.
DR   PANTHER; PTHR45726; LEUKOTRIENE A-4 HYDROLASE; 1.
DR   PANTHER; PTHR45726:SF3; LEUKOTRIENE A-4 HYDROLASE; 1.
DR   Pfam; PF09127; Leuk-A4-hydro_C; 1.
DR   Pfam; PF01433; Peptidase_M1; 1.
DR   Pfam; PF17900; Peptidase_M1_N; 1.
DR   PRINTS; PR00756; ALADIPTASE.
DR   SMART; SM01263; Leuk-A4-hydro_C; 1.
DR   SUPFAM; SSF48371; ARM repeat; 1.
DR   SUPFAM; SSF63737; Leukotriene A4 hydrolase N-terminal domain; 1.
DR   SUPFAM; SSF55486; Metalloproteases ('zincins'), catalytic domain; 1.
DR   PROSITE; PS00142; ZINC_PROTEASE; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Cytoplasm; Hydrolase; Leukotriene biosynthesis; Metal-binding;
KW   Metalloprotease; Phosphoprotein; Protease; Reference proteome; Zinc.
FT   CHAIN           1..611
FT                   /note="Leukotriene A-4 hydrolase"
FT                   /id="PRO_0000095126"
FT   ACT_SITE        297
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000250|UniProtKB:P09960"
FT   ACT_SITE        384
FT                   /note="Proton donor"
FT                   /evidence="ECO:0000250|UniProtKB:P09960"
FT   BINDING         135..137
FT                   /ligand="a peptide"
FT                   /ligand_id="ChEBI:CHEBI:60466"
FT                   /evidence="ECO:0000250|UniProtKB:P09960"
FT   BINDING         267..272
FT                   /ligand="a peptide"
FT                   /ligand_id="ChEBI:CHEBI:60466"
FT                   /evidence="ECO:0000250|UniProtKB:P09960"
FT   BINDING         296
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_note="catalytic"
FT                   /evidence="ECO:0000250|UniProtKB:P09960"
FT   BINDING         300
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_note="catalytic"
FT                   /evidence="ECO:0000250|UniProtKB:P09960"
FT   BINDING         319
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_note="catalytic"
FT                   /evidence="ECO:0000250|UniProtKB:P09960"
FT   BINDING         564..566
FT                   /ligand="a peptide"
FT                   /ligand_id="ChEBI:CHEBI:60466"
FT                   /evidence="ECO:0000250|UniProtKB:P09960"
FT   SITE            376
FT                   /note="Essential for epoxide hydrolase activity, but not
FT                   for aminopeptidase activity"
FT                   /evidence="ECO:0000250|UniProtKB:P09960"
FT   SITE            379
FT                   /note="Covalently modified during suicide inhibition by
FT                   leukotrienes"
FT                   /evidence="ECO:0000250|UniProtKB:P09960"
FT   MOD_RES         73
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P09960"
FT   MOD_RES         337
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P09960"
FT   MOD_RES         414
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P09960"
FT   MOD_RES         416
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P09960"
FT   MOD_RES         573
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P09960"
FT   CONFLICT        5
FT                   /note="A -> E (in Ref. 1; AAB21778)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        52
FT                   /note="S -> T (in Ref. 1; AAB21778)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        136..137
FT                   /note="CQ -> WE (in Ref. 1; AAB21778)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        151
FT                   /note="Missing (in Ref. 1; AAB21778)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        510
FT                   /note="K -> R (in Ref. 1; AAB21778)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   611 AA;  69089 MW;  350BDE2683C223C9 CRC64;
     MPEVADTCSL ASPASVCRTQ HLHLRCSVDF ARRALTGTAA LTVQSQEDNL RSLTLDTKDL
     TIEKVVINGQ EVKYTLGESQ GYKGSPMEIS LPIALSKNQE VVIEISFETS PKSSALQWLT
     PEQTSGKQHP YLFSQCQAIH CRAILPCQDT PSVKLTYTAE VSVPKELVAL MSAIRDGEAP
     DPEDPSRKIY RFNQRVPIPC YLIALVVGAL ESRQIGPRTL VWSEKEQVEK SAYEFSETES
     MLKIAEDLGG PYVWGQYDLL VLPPSFPYGG MENPCLTFVT PTLLAGDKSL SNVIAHEISH
     SWTGNLVTNK TWDHFWLNEG HTVYLERHIC GRLFGEKFRH FHALGGWGEL QNTIKTFGES
     HPFTKLVVDL KDVDPDVAYS SIPYEKGFAL LFYLEQLLGG PEVFLGFLKA YVEKFSYQSV
     TTDDWKSFLY AHFKDKVDLL NQVDWNAWLY APGLPPVKPN YDVTLTNACI ALSQRWVTAK
     EEDLNSFSIE DLKDLSSHQL NEFLAQVLQK APLPLGHIKR MQEVYNFNAI NNSEIRFRWL
     RLCIQSKWEE AIPLALKMAT EQGRMKFTRP LFKDLAAFDK SHDQAVRTYQ EHKACMHPVT
     AMLVGKDLKV D
//
